Man Group PLC Alnylam Pharmaceuticals, Inc. Transaction History

Man Group PLC

$37.6 Billion
Q2 2024

A detailed history of Man Group PLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Man Group PLC holds 117,910 shares of ALNY stock, worth $31.2 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

117,910

Previous 210,235 43.92%

Holding current value

$31.2 Million

Previous $31.4 Million 8.81%

% of portfolio

0.08%

Previous 0.08%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $13.2 Million - $22.8 Million	-92,325 Reduced 43.92%	117,910 $28.7 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $24.5 Million - $33.2 Million	167,345 Added 390.17%	210,235 $31.4 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $3.42 Million - $4.44 Million	22,594 Added 111.32%	42,890 $8.21 Million
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $5.19 Million - $6.43 Million	-30,383 Reduced 59.95%	20,296 $3.59 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $14.9 Million - $17.1 Million	-80,496 Reduced 61.37%	50,679 $9.63 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $23.6 Million - $30.5 Million	129,334 Added 7025.2%	131,175 $26.3 Million
Q4 2022 Feb 14, 2023	BUY	$185.53 - $241.31 $97,032 - $126,205	523 Added 39.68%	1,841 $437,000
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $8.4 Million - $14.1 Million	-60,624 Reduced 97.87%	1,318 $264,000
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $7.29 Million - $10.3 Million	60,568 Added 4408.15%	61,942 $9.03 Million
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $174,745 - $238,952	1,374 New	1,374 $224,000
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $549,365 - $720,585	-3,443 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $584,449 - $715,214	3,443 New	3,443 $650,000
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $2.54 Million - $3.51 Million	-19,992 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$122.97 - $147.0 $236,225 - $282,387	-1,921 Reduced 8.77%	19,992 $2.6 Million
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $4.48 Million - $6.12 Million	-36,971 Reduced 62.79%	21,913 $3.19 Million
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $5.85 Million - $8.79 Million	56,184 Added 2080.89%	58,884 $8.72 Million
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $47,956 - $69,004	-515 Reduced 16.02%	2,700 $294,000
Q4 2019 Feb 18, 2020	SELL	$74.51 - $124.23 $615,080 - $1.03 Million	-8,255 Reduced 71.97%	3,215 $370,000
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $1.81 Million - $2.24 Million	-25,482 Reduced 68.96%	11,470 $923,000
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $1.11 Million - $1.57 Million	16,890 Added 84.19%	36,952 $2.68 Million
Q1 2019 May 15, 2019	SELL	$72.76 - $93.45 $146,756 - $188,488	-2,017 Reduced 9.14%	20,062 $1.88 Million
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $205,620 - $289,810	-3,281 Reduced 12.94%	22,079 $1.61 Million
Q3 2018 Nov 14, 2018	SELL	$87.52 - $122.67 $858,571 - $1.2 Million	-9,810 Reduced 27.89%	25,360 $2.22 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $2.89 Million - $3.53 Million	32,770 Added 1365.42%	35,170 $3.46 Million
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $278,208 - $356,496	2,400 New	2,400 $286,000

Others Institutions Holding ALNY

# of Institutions

654

Shares Held

111M

Call Options Held

2.14M

Put Options Held

1.91M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $32.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account